Answers are grounded in this paper and cite their sources.
Prospective comparative study reveals next-generation SS-OCTA improves automated type 1 MNV detection under large PEDs, indicating manual segmentation remains essential to avoid missed diagnoses.
Purpose: Large pigment epithelial detachments (PEDs) compromise automated swept-source optical coherence tomography angiography (SS-OCTA) segmentation, leading to false-negative type 1 macular neovascularization (MNV) in neovascular age-related macular degeneration. We compared the diagnostic sensitivity of two SS-OCTA platforms from different generations to assess whether technological advances offset segmentation limitations. Methods: This was a prospective comparative study of 82 eyes with type 1 MNV and PED height ≥ 250 µm. Each eye underwent dual SS-OCTA imaging with a first-generation 1050-nm (100-kHz) system and a next-generation 1060-nm (400-kHz) system. Two masked readers evaluated automated versus manually adjusted segmentation slabs across PED height categories. Results: On the 1050-nm system, detection improved from 22.0% with automated segmentation to 81.7% after manual adjustment (P < 0.001). The 1060-nm system showed higher automated detection (68.3%), with a modest increase to 75.6% after manual segmentation. Stratified analysis showed superior automated performance of the 1060-nm device in shallow PEDs, whereas intermediate PEDs were most challenging for both systems. In very large PEDs, manual segmentation yielded similar detection rates on both devices. Conclusions: Detection of type 1 MNV beneath large PEDs is significantly device dependent. Although next-generation SS-OCTA systems improve automated detection, manual segmentation remains crucial for optimal sensitivity and accuracy. Device-specific protocols integrating routine manual review are warranted to avoid false-negative findings and treatment delays. Translational Relevance: Manual segmentation remains essential to prevent false-negative detection of type 1 MNV beneath large PEDs, even with next-generation SS-OCTA devices. This has direct implications for diagnostic protocols and treatment decisions in nAMD.
No takes yet. Share an insight, caveat, or question.
Idrissi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: